Vancouver
Canada
7
2023-04-06
7
2023-11-14
These are the the leading inventors for applications assigned to ESSA Pharma, Inc.:
ESSA Pharma, Inc. based in Vancouver, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
#2 | 2022-08-18 ✅ Patent 11,518,747 granted on 2022-12-06Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
#3 | 2022-07-14 ✅ Patent 12,109,179 granted on 2024-10-08Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
#4 | 2022-03-10 ✅ Patent 11,358,938 granted on 2022-06-14Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
#5 | 2021-10-28 ✅ Patent 11,242,324 granted on 2022-02-08Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof
#6 | 2021-07-01 ✅ Patent 11,485,713 granted on 2022-11-01Androgen receptor modulators and methods for their use
#7 | 2020-08-06 ✅ Patent 11,059,795 granted on 2021-07-13Androgen receptor modulators and methods for their use
Also check out ESSA Pharma, Inc.'s (Vancouver, Canada) applicant profile with 11 patent applications submitted.
371837 ⎘